Zurich
Meridan ReportZurich: Swiss precision in institutional finance

Advertisement · Why this ad?

Health

The excitement around Moderna’s cancer vaccine is cooling. Here’s why.

Marcus Chen
Managing Editor · Monday, October 26, 2026 at 1:50 PM · 1 min read
The excitement around Moderna’s cancer vaccine is cooling. Here’s why. — MarketWatch, Zurich Health news
Image: MarketWatch

Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.

Up nextMy spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair?Business · 1 min read
You're offline — showing the last loaded page